Ryan Cunningham

Author Archives

Aria CV, Inc. Closes on $7.8 million Series A Financing

SAINT PAUL, MN — July 24, 2015 — Aria CV, Inc., a developer of medical devices treating pulmonary hypertension, a serious condition that may lead to Read more...

Augmenix Announces Publication of SpaceOAR® System Clinical Trial Results in Leading Radiation Oncology Journal

Pivotal Study Demonstrates Product Safety and Patient Benefits in Men Undergoing Prostate Radiotherapy WALTHAM, Mass.—Augmenix, Inc., a medical Read more...

New England Journal of Medicine Publishes Study Results Suggesting Veracyte’s Percepta™ Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures in Lung Cancer Diagnosis

South San Francisco, Calif., Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced Read more...

100 Women in Hedge Funds: Investing in Healthcare

DATE: Wednesday, April 1st, 2015 at 5:30 PM Boston, MA Healthcare has been on fire! We continue to see significant IPO activity, soaring deal values Read more...

Veracyte Initiates Launch of Percepta™ Bronchial Genomic Classifier

South San Francisco, Calif. - Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostic company pioneering the field of molecular cytology, today announced Read more...

Provision first proton therapy center using new product to benefit prostate cancer patients

KNOXVILLE, Tenn. (WVLT)-- Provision Center for Proton Therapy is helping pioneer a new product that will help further protect prostate cancer patients Read more...

New prostate treatment protects from radiation effects

CHARDON, Ohio -- Two days ago, the FDA approved a new product that protects prostate cancer patients from the side effects of radiation. It's called Read more...

Immunoassay Confirmation of MRM-MS Data Supports a Role for Acute Phase Proteins in the Prediction of Spontaneous Preterm Birth

Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2015 Annual Meeting.  Read more...

First-in human: Tumor suctioned from vein of cancer patient to allow minimally invasive kidney surgery

Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing Read more...

Discovery Assay Development of Biomarkers Predictive of Preterm Birth

Sera Prognostics, Inc. presented the development and analytical performance of a highly multiplexed and targeted mass spectrometry-based assay for biomarker Read more...

Page 3 of 3123

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184